419 related articles for article (PubMed ID: 24644124)
1. Successful use of fondaparinux early after mechanical aortic valve replacement in a patient with a history of heparin-induced thrombocytopenia.
Willenborg KL
Pharmacotherapy; 2014 Jun; 34(6):e55-9. PubMed ID: 24644124
[TBL] [Abstract][Full Text] [Related]
2. Successful use of fondaparinux for bridging early after aortic and mitral mechanical heart valve replacement.
Perissinotti AJ; Dotson B; Baciewicz FA; Tennenberg SD
Ann Pharmacother; 2012 Mar; 46(3):e9. PubMed ID: 22353236
[TBL] [Abstract][Full Text] [Related]
3. Prolonged use of fondaparinux for perioperative bridging: a case report of a patient with mechanical heart valve and heparin-induced thrombocytopenia.
Wei M; Wang CT; Li DM; Song XJ
J Clin Pharm Ther; 2015 Dec; 40(6):702-5. PubMed ID: 26573868
[TBL] [Abstract][Full Text] [Related]
4. Successful use of fondaparinux in a patient with a mechanical heart valve replacement and a history of heparin-induced thrombocytopenia.
Corbett TL; Elher KS; Garwood CL
J Thromb Thrombolysis; 2010 Oct; 30(3):375-7. PubMed ID: 20571919
[TBL] [Abstract][Full Text] [Related]
5. Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia.
Lobo B; Finch C; Howard A; Minhas S
Thromb Haemost; 2008 Jan; 99(1):208-14. PubMed ID: 18217156
[TBL] [Abstract][Full Text] [Related]
6. Warfarin-associated multiple digital necrosis complicating heparin-induced thrombocytopenia and Raynaud's phenomenon after aortic valve replacement for adenocarcinoma-associated thrombotic endocarditis.
Warkentin TE; Whitlock RP; Teoh KH
Am J Hematol; 2004 Jan; 75(1):56-62. PubMed ID: 14695634
[TBL] [Abstract][Full Text] [Related]
7. Fondaparinux as alternative anticoagulant to warfarin or low-molecular-weight heparin for recurrent venous thrombosis.
Thachil J
Ann Pharmacother; 2014 Mar; 48(3):420-4. PubMed ID: 24473488
[TBL] [Abstract][Full Text] [Related]
8. Fondaparinux (Arixtra(R)), a safe alternative for the treatment of patients with heparin-induced thrombocytopenia?
Badger NO
J Pharm Pract; 2010 Jun; 23(3):235-8. PubMed ID: 21507819
[TBL] [Abstract][Full Text] [Related]
9. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
10. Fondaparinux therapy in a hemodialysis patient with heparin-induced thrombocytopenia type II.
Wellborn-Kim JJ; Mitchell GA; Terneus WF; Stowe CL; Malias MA; Sparkman GM; Hanson GW
Am J Health Syst Pharm; 2010 Jul; 67(13):1075-9. PubMed ID: 20554593
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of early parenteral anticoagulation as a bridge to warfarin after mechanical valve replacement.
Mathew JG; Spyropoulos AC; Yusuf A; Vincent J; Eikelboom J; Shestakovska O; Fremes S; Noora J; Guo L; Peterson M; Pai M; Whitlock R
Thromb Haemost; 2014 Dec; 112(6):1120-8. PubMed ID: 25183209
[TBL] [Abstract][Full Text] [Related]
12. Fondaparinux for thromboembolic treatment and prophylaxis of heparin-induced thrombocytopenia.
Efird LE; Kockler DR
Ann Pharmacother; 2006; 40(7-8):1383-7. PubMed ID: 16788093
[TBL] [Abstract][Full Text] [Related]
13. Low-dose fondaparinux in suspected heparin-induced thrombocytopenia in the critically ill.
Wester JP; Leyte A; Oudemans-van Straaten HM; Bosman RJ; van der Spoel JI; Haak EA; Porcelijn L; Zandstra DF
Neth J Med; 2007 Mar; 65(3):101-8. PubMed ID: 17387236
[TBL] [Abstract][Full Text] [Related]
14. Aniticoagulation in patients following prosthetic heart valve replacement.
Akhtar RP; Abid AR; Zafar H; Khan JS
Ann Thorac Cardiovasc Surg; 2009 Feb; 15(1):10-7. PubMed ID: 19262444
[TBL] [Abstract][Full Text] [Related]
15. Fondaparinux as a safe alternative for managing heparin-induced thrombocytopenia in postoperative cardiac surgery patients.
Cegarra-Sanmartín V; González-Rodríguez R; Paniagua-Iglesias P; Santamaría-Ortiz A; Cueva LF; Galán-Serrano J; Moral-García MV
J Cardiothorac Vasc Anesth; 2014 Aug; 28(4):1008-12. PubMed ID: 24439171
[TBL] [Abstract][Full Text] [Related]
16. Early postoperative anticoagulation after mechanical valve replacement: a systematic review.
Kulik A; Rubens FD; Wells PS; Kearon C; Mesana TG; van Berkom J; Lam BK
Ann Thorac Surg; 2006 Feb; 81(2):770-81. PubMed ID: 16427905
[TBL] [Abstract][Full Text] [Related]
17. A practical approach for bridging anticoagulation after mechanical heart valve replacement.
Steger V; Bail DH; Graf D; Walker T; Rittig K; Ziemer G
J Heart Valve Dis; 2008 May; 17(3):335-42. PubMed ID: 18592932
[TBL] [Abstract][Full Text] [Related]
18. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
Douketis JD; Johnson JA; Turpie AG
Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
[TBL] [Abstract][Full Text] [Related]
19. Early postoperative anticoagulation after mechanical valve replacement: a Canadian survey.
Kulik A; Rubens FD; Baird D; Wells PS; Kearon C; Mesana TG; Lam BK
J Heart Valve Dis; 2006 Jul; 15(4):581-7. PubMed ID: 16901058
[TBL] [Abstract][Full Text] [Related]
20. Early anticoagulation after mechanical valve implantation, and related complications.
Puri D; Kumar A; Basu R; Chaudhary A; Sarwal V; Sahoo M; Mahant TS
J Heart Valve Dis; 2008 Jul; 17(4):418-24; discussion 425. PubMed ID: 18751472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
